Most AI medical devices cleared for use were not tested on whether they improve patient outcomes

A new analysis of 1,357 AI-based medical devices authorized by the U.S. Food and Drug Administration found that only three were evaluated for their actual impact on patients’ health before approval. The authors warn that widespread deployment of untested AI tools in clinical decision support could pose significant patient safety risks and call for more rigorous outcome studies and post-market surveillance.